UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
New coronavirus affect related stocks in different ways
Amid mounting fears of the new coronavirus infection, share prices of relat...
by Jeong Sae-im
|
2020-01-30 17:36
라인
Celltrion tops list of pharmaceutical brand reputation in January
Celltrion took the top place in the domestic brand reputation list of pharm...
by Jeong Sae-im
|
2020-01-30 16:10
라인
Merck Korea worker commits suicide
After Merck Biopharma Korea shut down the general medicine (GM) division la...
by Kim Yun-mi
|
2020-01-30 16:09
라인
Astellas’ rheumatoid arthritis drug Smyraf wins regulatory nod
Astellas Pharma’s Smyraf (ingredient: peficitinib) obtained regulatory appr...
by Kim Yun-mi
|
2020-01-30 14:07
라인
Hanmi targets revenue of ₩100 billion from Rosuzet sales
Hanmi Pharmaceutical said it aims to earn 100 billion won ($85 million) fro...
by Shim Hyun-tai
|
2020-01-29 18:05
라인
Drugmaker cancels event for 1,000 doctors due to new coronavirus risk
The outbreak of China’s novel coronavirus is affecting not only the medical...
by Park Gi-taek
|
2020-01-29 15:51
라인
‘Dupixent revolutionary atopic dermatitis drug to end lack of fundamental treatment’
Sanofi's Dupixent (ingredient: dupilumab), the only biologic drug for a...
by Kim Yun-mi
|
2020-01-29 14:00
라인
Afstyla wins nod as new therapy for hemophilia A
Afstyla, a new preventive treatment for hemophilia A developed in Korea, ha...
by Kim Yun-mi
|
2020-01-24 08:18
라인
MIT promotes industrial liaison program to Korean drugmakers
“In Boston, corporations are making successful cases through collaboration ...
by Jeong Sae-im
|
2020-01-23 12:04
라인
'Reimbursement for Repatha to expand treatment options for ASCVD patients'
Amgen is set to expand treatment options for atherosclerotic cardiovascular...
by Lee Han-soo
|
2020-01-22 15:14
라인
Sales of antidiabetic SGLT-2 inhibitors grew 40% in 2019
The domestic sales of sodium-glucose transport protein-2 (SGLT-2) inhibitor...
by Kim Yun-mi
|
2020-01-22 15:10
라인
HanAll remains positive of eye treatment’s efficacy despite initial failure
HanAll Biopharma said that it has failed to meet the primary endpoint for i...
by Lee Han-soo
|
2020-01-21 15:12
라인
SK Biopharma’s US partner gets EMA nod for sleepiness treatment
Jazz Pharmaceuticals, SK Biopharmaceutical’s U.S. partner, has received sal...
by Lee Han-soo
|
2020-01-21 14:22
라인
Some Merck Korea workers commute from provinces to Seoul every day
Merck Biopharma Korea completed the closure of the general medicine (GM) di...
by Kim Yun-mi
|
2020-01-21 14:21
라인
Daewoong’s Jeuveau sold ₩40 billion in US in 8 months
Daewoong Pharmaceutical said the U.S. sales of its botulinum toxin Nabota (...
by Jeong Sae-im
|
2020-01-21 11:43
라인
CoImmune acquires Formula Pharmaceuticals
CoImmune, a joint venture set up by SCM Life Science and Genexine in the U....
by Lee Han-soo
|
2020-01-20 15:45
라인
Pfizer’s spinoff of generics unit causes disputes with trade union
Pfizer’s spinoff of its generics business division has made the employment ...
by Kim Yun-mi
|
2020-01-20 15:44
라인
Korea’s botulinum toxin exports hit record high in 2019
Exports of botulinum toxin products recorded the largest volume last year i...
by Jeong Sae-im
|
2020-01-20 11:38
라인
Takeda’s Kynteles expands indication for ulcerative colitis, Crohn’s disease
People with ulcerative colitis and Crohn’s disease who have failed with sta...
by Kim Yun-mi
|
2020-01-17 17:30
라인
GenScript to market Genopis' GMP-grade plasmid DNA
Genopis, a U.S offshoot of Helixmith, said that it has entered into a strat...
by Lee Han-soo
|
2020-01-17 17:28
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top